167 related articles for article (PubMed ID: 16604493)
1. [The expression of mutation p53 gene from circulating cancer cells of peripheral blood and the clinical significance in detecting the patients with colorectal cancer].
Ma GJ; Zhou JN; Shen ZL; Chen SQ; Zhu YQ; Wu XL; Xue KX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Apr; 23(2):186-8. PubMed ID: 16604493
[TBL] [Abstract][Full Text] [Related]
2. Immunoreactivity evaluation of mutant p53 gene product with DNA ploidy pattern in colorectal carcinoma.
Nasif WA; El-Emshaty HM; Tabll A; Elmasry SA; Attallah AM; Gad Elhak NA
Hepatogastroenterology; 2004; 51(58):1001-6. PubMed ID: 15239234
[TBL] [Abstract][Full Text] [Related]
3. Staining patterns of p53 immunohistochemistry and their biological significance in colorectal cancer.
Kaserer K; Schmaus J; Bethge U; Migschitz B; Fasching S; Walch A; Herbst F; Teleky B; Wrba F
J Pathol; 2000 Mar; 190(4):450-6. PubMed ID: 10699994
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance in molecular detection of p53 mutation in serum of patients with colorectal carcinoma.
Ito T; Kaneko K; Makino R; Konishi K; Kurahashi T; Ito H; Katagiri A; Kushima M; Kusano M; Mitamura K; Imawari M
Oncol Rep; 2003; 10(6):1937-42. PubMed ID: 14534722
[TBL] [Abstract][Full Text] [Related]
5. [Peripheral blood p53 single nucleotide polymorphism analysis for early diagnosis of colorectal carcinoma].
Liu Q; Lai ZS; Wnag W; Zhang Y; Zhou M
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Dec; 27(12):1939-40. PubMed ID: 18159026
[TBL] [Abstract][Full Text] [Related]
6. Have p53 gene mutations and protein expression a different biological significance in colorectal cancer?
Bazan V; Migliavacca M; Tubiolo C; Macaluso M; Zanna I; Corsale S; Amato A; Calò V; Dardanoni G; Morello V; La Farina M; Albanese I; Tomasino RM; Gebbia N; Russo A
J Cell Physiol; 2002 May; 191(2):237-46. PubMed ID: 12064467
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
[TBL] [Abstract][Full Text] [Related]
8. Familial and nutritional risk factors for p53 overexpression in colorectal cancer.
Freedman AN; Michalek AM; Marshall JR; Mettlin CJ; Petrelli NJ; Black JD; Zhang ZF; Satchidanand S; Asirwatham JE
Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):285-91. PubMed ID: 8722220
[TBL] [Abstract][Full Text] [Related]
9. Association of angiogenesis markers with lymph node metastasis in early colorectal cancer.
Iddings DM; Koda EA; Grewal SS; Parker R; Saha S; Bilchik A
Arch Surg; 2007 Aug; 142(8):738-44; discussion 744-5. PubMed ID: 17709727
[TBL] [Abstract][Full Text] [Related]
10. Molecular detection of circulating cancer cells in the peripheral blood of patients with colorectal cancer by using membrane array with a multiple mRNA marker panel.
Yeh CS; Wang JY; Wu CH; Chong IW; Chung FY; Wang YH; Yu YP; Lin SR
Int J Oncol; 2006 Feb; 28(2):411-20. PubMed ID: 16391796
[TBL] [Abstract][Full Text] [Related]
11. p53 as an indicator of lymph node metastases in invasive early colorectal cancer.
Makino M; Yamane N; Taniguchi T; Honboh T; Kurayoshi K; Kaibara N
Anticancer Res; 2000; 20(3B):2055-9. PubMed ID: 10928151
[TBL] [Abstract][Full Text] [Related]
12. Different p53 mutation patterns in colorectal tumors from smokers and nonsmokers.
Huang CC; Cheng YW; Chen MC; Lin YS; Chou MC; Lee H
Environ Mol Mutagen; 2006 Aug; 47(7):527-32. PubMed ID: 16721749
[TBL] [Abstract][Full Text] [Related]
13. Carcinoembryonic gene member 2 mRNA expression as a marker to detect circulating enterocytes in the blood of colorectal cancer patients.
Douard R; Le Maire V; Wind P; Sales JP; Dumas F; Fayemendi L; Landi B; Benichou J; Cugnenc PH; Gayral F; Loric S
Surgery; 2001 May; 129(5):587-94. PubMed ID: 11331451
[TBL] [Abstract][Full Text] [Related]
14. P53 mutations in primary and metastatic tumors and circulating tumor cells from colorectal carcinoma patients.
Khan ZA; Jonas SK; Le-Marer N; Patel H; Wharton RQ; Tarragona A; Ivison A; Allen-Mersh TG
Clin Cancer Res; 2000 Sep; 6(9):3499-504. PubMed ID: 10999735
[TBL] [Abstract][Full Text] [Related]
15. Development and evaluation of a colorimetric membrane-array method for the detection of circulating tumor cells in the peripheral blood of Taiwanese patients with colorectal cancer.
Wang JY; Yeh CS; Chen YF; Wu CH; Hsieh JS; Huang TJ; Huang SY; Lin SR
Int J Mol Med; 2006 May; 17(5):737-47. PubMed ID: 16596255
[TBL] [Abstract][Full Text] [Related]
16. [p53 mutations and protein overexpression in primary colorectal cancer and its liver metastasis].
Yang Y; Xia Q; Lian F
Zhonghua Zhong Liu Za Zhi; 1999 Mar; 21(2):114-8. PubMed ID: 11776850
[TBL] [Abstract][Full Text] [Related]
17. [Chemotherapeutic failure in micrometastasis in peripheral blood of patients with colorectal carcinomas].
Luo C; Li S
Zhonghua Wai Ke Za Zhi; 1999 Jul; 37(7):421-3. PubMed ID: 11829878
[TBL] [Abstract][Full Text] [Related]
18. Colon cancer: p53 expression and DNA ploidy. Their relation to proximal or distal tumor site.
García-Hirschfeld García J; Blanes Berenguel A; Vicioso Recio L; Márquez Moreno A; Rubio Garrido J; Matilla Vicente A
Rev Esp Enferm Dig; 1999 Jul; 91(7):481-8. PubMed ID: 10477366
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of genetic mutations of tumor suppresser genes in colorectal cancer patients.
Kubo H; Miki C; Kusunoki M
Hepatogastroenterology; 2004; 51(55):114-7. PubMed ID: 15011843
[TBL] [Abstract][Full Text] [Related]
20. Serum anti-p53 in relation to mutations across the entire translated p53 gene in colorectal carcinomas.
Forslund A; Kressner U; Lindmark G; Inganäs M; Lundholm K
Int J Oncol; 2001 Sep; 19(3):501-6. PubMed ID: 11494027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
